• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

AdvanDx

edit

AdvanDx, Inc. develops and markets vitro diagnostic kits for the diagnosis and prevention of infectious diseases.

The company provides its products to medical centers, reference labs, government institutions, and community hospitals. Its products are available through a network of sales force in United States, as well as through distributors around the world.

AdvanDX was founded in 2002 and is based in Woburn, Massachusetts.

Milestones

edit

• 
  AdvanDx added Henrik Stender as Founder.
  Posted 10/12/09 at 6:05pm
• 
  AdvanDx added Thais T. Johansen as Founder.
  Posted 10/12/09 at 6:05pm
• 
  AdvanDx received $8M in Series C funding. (10/12/09)
  Posted 10/12/09 at 6:05pm via onbiovc.com
• 
  AdvanDx — has won approval from the FDA for its speedy blood test for simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa infections (1/17/11)
  Posted 1/17/11 at 10:59am via masshightech.com

Videos

Screenshots

edit

Sources

1. AdvanDx, Inc.: Series C $8M (onbiovc.com) [edit]
2. AdvanDx wins FDA OK for speedy blood infection test (masshightech.com) [edit]